CIBC Private Wealth Group
ALDR

CIBC Private Wealth Group’s Alder Biopharmaceuticals ALDR Stock Holding History

CIBC Private Wealth Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$16K – 1922
2018
Q2 		$16K Buy
+1,000
New +$15.2K ﹤0.01% 1467

Other funds holding ALDR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIBC Private Wealth Group's ALDR Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Alder Biopharmaceuticals (ALDR) in Q3 2018, closing a stake of 1,000 shares — an estimated $16K sold.

CIBC Private Wealth Group first reported a position in ALDR in Q2 2018 and held it in 1 quarter. The position peaked at $16K in Q2 2018. 128 funds tracked by Wall St. Rank hold ALDR as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Alder Biopharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 1,000 Alder Biopharmaceuticals shares in Q3 2018, an estimated $16K.
  • CIBC Private Wealth Group first reported a position in Alder Biopharmaceuticals in Q2 2018 and held it in 1 quarter.
  • CIBC Private Wealth Group's Alder Biopharmaceuticals position peaked at $16K in Q2 2018.
  • 128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.